Dedham, MA, United States of America

Michael Morin


Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Morin: Innovator in Nucleic Acid Amplification Technology

Introduction

Michael Morin is a notable inventor based in Dedham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of disposable test devices for nucleic acid amplification reactions. His innovative approach has the potential to enhance the efficiency and accessibility of nucleic acid testing.

Latest Patents

Michael Morin holds a patent for a disposable test device designed for performing nucleic acid amplification reactions. This unit dose test device takes the form of an elongate disposable test strip. The test strip features a dual-chamber reaction vessel that is pre-loaded with nucleic acid amplification reaction reagents. Additionally, it includes a plurality of wells for processing reactions occurring in the reaction vessel. This invention represents a significant advancement in the field of molecular diagnostics.

Career Highlights

Michael Morin is currently employed at bioMérieux, Inc., a company renowned for its commitment to improving public health through innovative diagnostic solutions. His work at bioMérieux has allowed him to apply his expertise in developing cutting-edge technologies that facilitate rapid and accurate testing.

Collaborations

Throughout his career, Michael has collaborated with several talented individuals, including Bryan W. Kluttz and Lawrence Burg. These collaborations have contributed to the advancement of technologies in the field of diagnostics and have fostered a spirit of innovation within the team.

Conclusion

Michael Morin's contributions to the field of nucleic acid amplification technology exemplify the impact of innovative thinking in biotechnology. His patent for a disposable test device showcases his commitment to enhancing diagnostic capabilities. Through his work at bioMérieux, he continues to push the boundaries of what is possible in molecular diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…